Researchers reported that colorectal cancer cells that are insensitive to single-agent enhancer of zeste homolog 2 (EZH2) inhibition become sensitive as compensatory lysine-27 trimethylation on histone H3 mediated silencing emerges upon DNA methyltransferase inhibitor (DNMTi) treatment.
[Science Advances]